EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

The miR-21-5p, miR-30c-5p, and miR-182-5p as Biomarkers in Clear Cell Renal Cell Carcinoma: A Southeastern Romanian Cohort Study

Ionuț Burlacu, Mariana Așchie, Georgeta Camelia Cozaru iD, Mariana Deacu iD, Gabriela Miruna Vizireanu iD, Adrian Nelutu Mitroi, Anca Florentina Mitroi, Costel Stelian Brînzan iD

Genes · 2025

DOI: 10.3390/genes16060650 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Genes, 2025. Verfasst von Ionuț Burlacu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, Sf. Apostol Andrei Clinical Emergency County Hospital, 145 Tomis Blvd, 900591 Constanta, Romania. Hauptthemen laut MEDLINE: MicroRNAs, Carcinoma, Renal Cell, Biomarkers, Tumor, Kidney Neoplasms. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ovidius University, “Ovidius” University of Constanta.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to evaluate the expression and clinical relevance of three mature miRNAs (miR-21-5p, miR-30c-5p, and miR-182-5p) in patients with clear cell renal cell carcinoma (ccRCC) from southeast Romania, and to explore their potential as non-invasive diagnostic and prognostic biomarkers. Methods: miRNA expression levels were measured using TaqMan® MGB and qRT-PCR in paired tumor and adjacent non-cancerous tissues, as well as in serum-derived exosomes, from 26 ccRCC patients. Statistical analysis included the Wilcoxon test for group comparisons and non-parametric tests for correlations with clinicopathological features. Receiver operating characteristic (ROC) curves were used to assess diagnostic performance, and miRNA panels were constructed for improved accuracy.

Results

Significant dysregulation of the investigated miRNAs was observed. miR-21-5p was markedly overexpressed in both tumor tissues (3.46-fold, p < 0.001) and serum exosomes (3.26-fold, p < 0.001). miR-182-5p showed modest overexpression in tissues (0.56-fold, p < 0.001) and serum (0.85-fold, p < 0.001), whereas miR-30c-5p was significantly downregulated in both tissues (2.48-fold decrease, p < 0.001) and serum exosomes (2.29-fold decrease, p = 0.0003). Elevated miR-182-5p expression correlated with tumor localization in the right kidney (p = 0.02) and lymph node involvement (p = 0.04). Similarly, higher miR-21-5p levels in serum exosomes were associated with right-sided tumors (p = 0.01). ROC analysis revealed distinct expression profiles for all three miRNAs between ccRCC and normal tissue, both in tissue and exosomal samples (all p < 0.05). Combined biomarker panels yielded high diagnostic performance (AUC = 0.94 for tissue, AUC = 0.93 for exosomes).

Conclusions

This study underscores the potential of miR-21-5p, miR-30c-5p, and miR-182-5p as non-invasive biomarkers for ccRCC diagnosis and prognosis. The use of serum exosomal miRNA panels offers a promising alternative to tissue-based diagnostics in Romanian ccRCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsCarcinoma, Renal CellBiomarkers, TumorKidney NeoplasmsHumansMaleFemaleMiddle AgedRomaniaGene Expression Regulation, NeoplasticExosomesAgedPrognosisAdultCohort Studies

Stichwörter der Autor:innen

clear cell renal cell carcinomaexosomesmiR-182-5pmiR-21-5pmiR-30c-5pnon-invasive diagnosisqRT-PCR

Substanzen

MicroRNAsBiomarkers, TumorMirn182 microRNA, humanMIRN21 microRNA, human

Autor:innen und Institutionen

  • Pathology Department, Sf. Apostol Andrei Clinical Emergency County Hospital, 145 Tomis Blvd, 900591 Constanta, Romania.
  • CEDMOG Center, Ovidius University, 145 Tomis Blvd., 900527 Constanta, Romania.
  • Faculty of Medicine, Ovidius University, 145 Tomis Blvd., 900527 Constanta, Romania.
  • CFR Hospital Constanta, Boulevard 1 Mai 3-5, 900123 Constanta, Romania.

ORCID-Profile: Georgeta Camelia Cozaru, Mariana Deacu, Gabriela Miruna Vizireanu, Costel Stelian Brînzan

Förderung

  • Ovidius University
  • “Ovidius” University of Constanta

Zitieren

APA

Burlacu, I., Așchie, M., Cozaru, G. C., Deacu, M., Vizireanu, G. M., Mitroi, A. N., Mitroi, A. F., & Brînzan, C. S. (2025). The miR-21-5p, miR-30c-5p, and miR-182-5p as Biomarkers in Clear Cell Renal Cell Carcinoma: A Southeastern Romanian Cohort Study. Genes. https://doi.org/10.3390/genes16060650

Vancouver

Burlacu I, Așchie M, Cozaru GC, Deacu M, Vizireanu GM, Mitroi AN, et al. The miR-21-5p, miR-30c-5p, and miR-182-5p as Biomarkers in Clear Cell Renal Cell Carcinoma: A Southeastern Romanian Cohort Study. Genes. 2025. doi:10.3390/genes16060650

BibTeX
@article{Burlacu2025,
  author = {Burlacu, Ionuț and Așchie, Mariana and Cozaru, Georgeta Camelia and Deacu, Mariana and Vizireanu, Gabriela Miruna and Mitroi, Adrian Nelutu and Mitroi, Anca Florentina and Brînzan, Costel Stelian},
  title = {The miR-21-5p, miR-30c-5p, and miR-182-5p as Biomarkers in Clear Cell Renal Cell Carcinoma: A Southeastern Romanian Cohort Study},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16060650}
}
Kostenlos starten →